MSB 4.00% $1.17 mesoblast limited

Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-159

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 30,371 Posts.
    lightbulb Created with Sketch. 1857
    Excellent find CC! Solid sources. The targeting of the cells to the inflammation sites was a challenge with the CHF trials from a while back.

    We'd get a load of 'the cells are no good' posts and I'd say actually it's an issue about delivery.

    This is just so good!


    (meanwhile It's unbelievable that we get so many confuse 'em with sciencey sounding spoofs not even relying on scientific sources).



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.